MedPath

Isordil

Isordil® Titradose® (isosorbide dinitrate) Tablets

Approved
Approval ID

8ddd2577-311a-4967-bb67-ad72e2b76f83

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 8, 2019

Manufacturers
FDA

Bausch Health US LLC

DUNS: 831922468

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

isosorbide dinitrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0187-0192
Application NumberNDA012093
Product Classification
M
Marketing Category
C73594
G
Generic Name
isosorbide dinitrate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 8, 2019
FDA Product Classification

INGREDIENTS (6)

POWDERED CELLULOSEInactive
Code: SMD1X3XO9M
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
ISOSORBIDE DINITRATEActive
Quantity: 40 mg in 1 1
Code: IA7306519N
Classification: ACTIB

isosorbide dinitrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0187-0152
Application NumberNDA012093
Product Classification
M
Marketing Category
C73594
G
Generic Name
isosorbide dinitrate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 8, 2019
FDA Product Classification

INGREDIENTS (4)

FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
ISOSORBIDE DINITRATEActive
Quantity: 5 mg in 1 1
Code: IA7306519N
Classification: ACTIB
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Isordil - FDA Drug Approval Details